NAFLD vs MASLD (Metabolic Dysfunction–Associated Steatotic Liver Disease)—Why the Need for a Change of Nomenclature?

• by Amalia Gastaldelli, Philip N Newsome

• February 19, 2025

Schisandra chinensis Fructus and its active metabolites for the treatment of metabolic dysfunction-associated steatotic liver disease

• by Li Jun Wang, Ping Zhang, Gui Li Wang, Shu Cheng Chen, Wei You Cao, Ji Chun Han, Jian Guang Sun, Jian Chao Feng, Yang Zheng

• May 13, 2026

AHA Issues Pediatric Hypertriglyceridemia Statement

The scientific statement defines pancreatitis and atherosclerotic cardiovascular disease risk thresholds and outlines causes and management in youths.

• by Kathryn Wighton

• February 26, 2026

• 5 min

Hidden Gene Error Found in Fatty Liver

Exome sequencing reveals a rare MET mutation in liver disease

• March 20, 2026

• 2 min